Contact Us

Opening hours: Monday to Friday: 8:00am to 5:00pm, Saturday: 8:30am to 12:30pm

Study shows that having red meat before exercise does not offer any additional benefits

Cr. Victoria Shes

Source from MIMS.com

A new study has shown that people who are consuming lean red meat in line with current recommendations does not improve muscle mass, strength, nor cognitive functions of healthy community-dwelling older adults undertaking resistance-based exercise training 3 days/week compared to those consuming carbohydrates.

154 random adults aged ≥65 years was picked by the researchers as they participated in a multicomponent 3-day/week resistance-based exercise programme to either a lean red meat group, the exercise plus lean red meat or a control group receiving carbohydrates in the form of one-half cup or rice or pasta or 1 medium potato, the exercise plus carbohydrate control, on training days.

For the primary outcomes in total body lean mass, leg LM, thigh muscle cross-sectional area, leg and back muscle strength, and executive function;  there were no significant differences between-groups in exercise-induced improvements.

There were also no significant differences in improvements for the secondary outcomes of global cognition function, fat mass, physical function measures, or systolic blood pressure.

In terms of arm Lm, gait speed, muscle density, and appendicular LM in the per-protocol analysis, the improvements were greater for the Ex + meat group than the C + Ex group.

At the same time, net improvements in working memory learning after 12 weeks and 24 weeks were greater in the C + Ex group than the Ex + Meat group.

Share the post!

Bleeding and cardiovascular risks heightens after consumption of NSAIDs

Cr. JESHOOTS.com

Source from MIMS.com

Researchers conducted a study that investigated the risk for cardiovascular and bleeding events according to groups of antithrombotic medications and subtypes of NSAIDs. The first diagnosed MI in the nationwide cohort study was retrieved from 108,232 patients that they have accessed the Health Insurance Review and Assessment Service database between 2009 and 2013.

Based on their prescribed antithrombotic medications, the patients were divided into groups  with the thromboembolic cardiovascular and clinically relevant bleeding events as the study outcomes.

Concomitant NSAID treatment significantly elevated the risk for cardiovascular events and bleeding events compared with no NSAID treatment over a mean follow-up of 2.3 years. Celecoxib and meloxicam showed the lowest risk of cardiovascular and bleeding events among NSAID subtypes.

The authors stated in their research that although NSAID treatment should be avoided after MI, celecoxib and meloxicam could be considered as alternative options in cases in which NSAID use is unavoidable.

Share the post!